According to Healio (11/17, Herpen), investigators “have developed an online platform of metrics designed to assess a patient’s risk for developing Alzheimer’s disease” (AD) “and other neurological issues.” Called the Brain Health Platform, the metrics platform “is an advanced series of tests that determine the risk for dementia by combining three measures – a Resilience Index (RI), a Vulnerability Index (VI) and a Number-Symbol Coding Task,” which, when “combined…help assess the risk for developing AD and other related conditions.” The 230-participant study revealed that “participants with abnormal test scores were 95.7% likely to be impaired.” The findings were published online ahead of print in the Journal of Alzheimer’s Disease. (SOURCE: APA Headlines)